Ingo K. Mellinghoff

Also affiliated with Cornell University, Organogenesis (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.393Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2‐wildtype astrocytomas

Brain Pathology(2020)10.1111/bpa.12826

Top 46%

0.393DataRank

Top 46%5 citations

Marc K. Rosenblum, Ingo K. Mellinghoff, Viviane Tabar, Shahiba Ogilvie, Lauren Schaff +6 more

Papers

Driven by 29 papers — median percentile 54. Top paper: “Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial”.

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0611

N/A

4.8DataRank · unranked

264 citations

Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú +16 more

Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

Proceedings of the National Academy of Sciences(2007)10.1073/pnas.0710052104

N/A

1.0DataRank · unranked

1085 citations

Gad Getz, Leia Nghiemphu, Jordi Barretina, Teli Hsueh, David Linhart +31 more

Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies

European Journal of Nuclear Medicine and Molecular Imaging(2021)10.1007/s00259-021-05386-0

N/A

0.831DataRank · unranked

21 citations

Audrey Mauguen, Onur Yıldırım, Vaios Hatzoglou, Jasmine H. Francis, Lauren Schaff +4 more

Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2223734

N/A

0.431DataRank · unranked

9 citations

Elena Pentsova, Lauren Schaff, Craig Nolan, Thomas Kaley, Anne S. Reiner +3 more

Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2‐wildtype astrocytomas

Brain Pathology(2020)10.1111/bpa.12826

Top 46%

0.393DataRank

Top 46%5 citations

Marc K. Rosenblum, Ingo K. Mellinghoff, Viviane Tabar, Shahiba Ogilvie, Lauren Schaff +6 more

18F-BMS-986229 PET imaging of tumor PD-L1 expression in glioblastoma patients

EJNMMI Research(2025)10.1186/s13550-025-01283-x

N/A

0.175DataRank · unranked

2 citations

Mariza Daras, Tejus Bale, Serge K. Lyashchenko, Anne S. Reiner, Ingo K. Mellinghoff +3 more

Noninvasive Imaging of CD4+ T Cells in Humanized Mice

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0888

N/A

0DataRank · unranked

12 citations

Charli Ann J. Hertz, Kelly E. Henry, Maya Srikanth Graham, Carl Campos, Nagavarakishore Pillarsetty +4 more

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-1083

N/A

0DataRank · unranked

6 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Glioblastoma and Other Primary Brain Malignancies in Adults

JAMA(2023)10.1001/jama.2023.0023

N/A

0DataRank · unranked

1198 citations

Ingo K. Mellinghoff, Lauren Schaff

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Nature Communications(2023)10.1038/s41467-022-35592-9

N/A

0DataRank · unranked

52 citations

Henry Walch, Jaclyn F. Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck +23 more

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1

Neuro-Oncology(2023)10.1093/neuonc/noad033

N/A

0DataRank · unranked

35 citations

Anna F. Piotrowski, Jian Campian, Jose Diarte, Fausto J. Rodríguez, Tejus Bale +7 more

Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1180

N/A

0DataRank · unranked

31 citations

Raquel Moreno, Anne S. Reiner, Subhiksha Nandakumar, Henry Walch, Teena M. Thomas +12 more

Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1015

N/A

0DataRank · unranked

7 citations

Nicholas D. Socci, Travis J. Hollmann, Ingo K. Mellinghoff, Maryam Pourmaleki

Data from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

(2023)10.1158/1078-0432.c.6530541.v1

N/A

0DataRank · unranked

0 citations

Kelly E. Henry, Charli Ann J. Hertz, Maya Srikanth Graham, Carl Campos, Luis F. Parada +5 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763.v1

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0605

N/A

0DataRank · unranked

25 citations

Subhiksha Nandakumar, Lauren Schaff, Igor T. Gavrilovic, Thomas Kaley, Craig Nolan +21 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond

American Society of Clinical Oncology Educational Book(2024)10.1200/edbk_431450

N/A

0DataRank · unranked

19 citations

Μαρία Ιωάννου, Marjolein Geurts, Martin J. van den Bent, Ingo K. Mellinghoff, Karisa C. Schreck +1 more

Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0942

N/A

0DataRank · unranked

13 citations

Caitlin J. Jones, Sabrina D. Mellinghoff, Brian D. Greenstein, Priyadarshini Kumar, Miguel Foronda +11 more

CTNI-66. IDH-MUTANT GLIOMA PATIENTS TREATED WITH VORASIDENIB: ONGOING DATA FROM THE VORASIDENIB EXPANDED ACCESS PROGRAM

Neuro-Oncology(2024)10.1093/neuonc/noae165.0433

N/A

0DataRank · unranked

1 citations

Katherine B. Peters, Howard Colman, Jennie Taylor, Ingo K. Mellinghoff, Helen A. Shih +4 more

Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

The Journal of Clinical Endocrinology & Metabolism(2025)10.1210/clinem/dgaf178

N/A

0DataRank · unranked

10 citations

Vasilisa A. Rudneva, Adam Newton, Nazanin Majd, Rajiv Magge, Soma Sengupta +12 more

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

Acta Neuropathologica(2025)10.1007/s00401-025-02935-x

N/A

0DataRank · unranked

2 citations

Miika Mehine, Yelena Kemel, Chaitanya Bandlamudi, Diana Mandelker, Marc K. Rosenblum +36 more

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment

Neuro-Oncology Practice(2025)10.1093/nop/npaf109

N/A

0DataRank · unranked

0 citations

Anne S. Reiner, William E. Rosa, Brandon S. Imber, Luke Pike, Louis Voigt +12 more

Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment

Neuro-Oncology(2020)10.1093/neuonc/noaa105

N/A

0DataRank · unranked

52 citations

Robert J. Young, Benjamin M. Ellingson, Harini Veeraraghavan, Wei Wang, Florent Tixier +12 more

Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy

International Journal of Molecular Sciences(2020)10.3390/ijms21197193

N/A

0DataRank · unranked

22 citations

Ingo K. Mellinghoff, Maya Srikanth Graham

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51009

N/A

0DataRank · unranked

46 citations

Katherine S. Panageas, Elena Pentsova, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic +8 more

Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3243

N/A

0DataRank · unranked

45 citations

Kelly E. Henry, Charli Ann J. Hertz, Maya Srikanth Graham, Carl Campos, Luis F. Parada +5 more

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Neuro-Oncology(2022)10.1093/neuonc/noac086

N/A

0DataRank · unranked

23 citations

Elizabeth R. Gerstner, Andrew B. Lassman, Caroline Chung, Howard Colman, Patricia E. Cole +21 more

Ingo K. Mellinghoff

Indexed papers

Top data-sharing exemplar

Papers